Allspring Global Investments Holdings, LLC Argenx Se Transaction History
Allspring Global Investments Holdings, LLC
- $54.8 Billion
- Q2 2025
A detailed history of Allspring Global Investments Holdings, LLC transactions in Argenx Se stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 184,987 shares of ARGX stock, worth $118 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
184,987
Previous 176,450
4.84%
Holding current value
$118 Million
Previous $104 Million
2.36%
% of portfolio
0.19%
Previous 0.19%
Shares
13 transactions
Others Institutions Holding ARGX
# of Institutions
491Shares Held
28.3MCall Options Held
370KPut Options Held
211K-
Price T Rowe Associates Inc Baltimore, MD4.98MShares$3.18 Billion0.31% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.78 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.57MShares$1.64 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.95MShares$1.24 Billion0.16% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.18MShares$749 Million11.81% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.3B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...